Human Rotavirus Vaccine from China
A live attenuated oral vaccine containing reassortant rotaviruses for active immunization against rotavirus gastroenteritis in infants. Classified under HTS 3002.49.0050 as it is a vaccine for human use, other than those specifically enumerated elsewhere in heading 3002. It is prepared for prophylactic purposes via biotechnological processes.
Duty Rate — China → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Obtain FDA import permit and biologics license; maintain cold chain documentation throughout transit to preserve efficacy
• Declare exact strain and dosage form; provide lot release certificates from manufacturer to avoid holds